Infliximab eye drops treatment in corneal neovascularization

Corneal neovascularization is a serious condition that may arise secondary to chemical burns, ischemia, infection, trauma, and inflammation and represents a major cause of blindness. This study investigated the efficacy of topical application of infliximab [tumor necrosis factor-a (TNF-a) monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Voiculescu, OB, Voinea, LM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2015
Materias:
Young Researchers Area
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656973/
https://www.ncbi.nlm.nih.gov/pubmed/26664491
_version_ 1782402308583194624
author Voiculescu, OB
Voinea, LM
author_facet Voiculescu, OB
Voinea, LM
author_sort Voiculescu, OB
collection PubMed
description Corneal neovascularization is a serious condition that may arise secondary to chemical burns, ischemia, infection, trauma, and inflammation and represents a major cause of blindness. This study investigated the efficacy of topical application of infliximab [tumor necrosis factor-a (TNF-a) monoclonal antibody] in the treatment of corneal neovascularization in the rabbit model.
format Online
Article
Text
id pubmed-4656973
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-46569732015-12-10 Infliximab eye drops treatment in corneal neovascularization Voiculescu, OB Voinea, LM J Med Life Young Researchers Area Corneal neovascularization is a serious condition that may arise secondary to chemical burns, ischemia, infection, trauma, and inflammation and represents a major cause of blindness. This study investigated the efficacy of topical application of infliximab [tumor necrosis factor-a (TNF-a) monoclonal antibody] in the treatment of corneal neovascularization in the rabbit model. Carol Davila University Press 2015 /pmc/articles/PMC4656973/ /pubmed/26664491 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Young Researchers Area
Voiculescu, OB
Voinea, LM
Infliximab eye drops treatment in corneal neovascularization
title Infliximab eye drops treatment in corneal neovascularization
title_full Infliximab eye drops treatment in corneal neovascularization
title_fullStr Infliximab eye drops treatment in corneal neovascularization
title_full_unstemmed Infliximab eye drops treatment in corneal neovascularization
title_short Infliximab eye drops treatment in corneal neovascularization
title_sort infliximab eye drops treatment in corneal neovascularization
topic Young Researchers Area
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656973/
https://www.ncbi.nlm.nih.gov/pubmed/26664491
work_keys_str_mv AT voiculescuob infliximabeyedropstreatmentincornealneovascularization
AT voinealm infliximabeyedropstreatmentincornealneovascularization

Ejemplares similares